Publicaciones en las que colabora con J. Solé Violán (11)

2023

  1. Effectiveness of prolonged versus standard-course of oseltamivir in critically ill patients with severe influenza infection: A multicentre cohort study

    Journal of Medical Virology, Vol. 95, Núm. 8

2022

  1. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

2021

  1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

    Science immunology, Vol. 6, Núm. 62

  2. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia

    ERJ Open Research, Vol. 7, Núm. 1

2018

  1. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

2017

  1. Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case–control study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 1, pp. 123-130

2016

  1. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis

    Journal of Infection, Vol. 72, Núm. 2, pp. 143-151

2015

  1. Pneumococcal pneumonia coinfection in critically ill patients with influenza a (H1n1) primary viral pneumonia

    Intensive Care Medicine Experimental

2014

  1. Decrease in Mortality in severe community-acquired pneumococcal pneumonia: Impact of improving antibiotic strategies (2000-2013)

    Chest, Vol. 146, Núm. 1, pp. 22-31

2013

  1. Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy

    Medicina Intensiva, Vol. 37, Núm. 5, pp. 320-326

2012

  1. Recomendaciones del Grupo de Trabajo Enfermedades Infecciosas (GTEI) de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) y el Grupo de Estudio de Infecciones en el Paciente Crítico (GEIPC) de la Sociedad Espanola de Enfermedades Infecciosas y Microbiología clinica (SEIMC) para el diagnóstico y tratamiento de la gripe A/H1N1

    Medicina Intensiva, Vol. 36, Núm. 2, pp. 103-137